Anti-human MHC Class I (HLA-A, HLA-B, HLA-C)-InVivo

目录号：A2172         批次号: A217204

       克隆号：W6/32

打印

Anti-human MHC Class I (HLA-A, HLA-B, HLA-C)-InVivo与人类主要组织相容性复合体（MHC）I 类， HLA-A、B 和 C 发生反应。所有人类有核细胞均表达与 β2-微球蛋白相关的 MHC I 类抗原。MHC I 类抗原在细胞介导的免疫应答和肿瘤监视中发挥核心作用。

抗体信息

克隆号 W6/32
配制 PBS, pH 7.0. Contains no stabilizers or preservatives
推荐同型对照 mouse IgG2a,κ
应用 Anti-human MHC Class I (HLA-A, HLA-B, HLA-C)-InVivo
来源 CHO
小鼠病原体检测 all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus.
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 7.05 mg/ml
内毒素 ＜1EU/mg

Anti-human MHC Class I (HLA-A, HLA-B, HLA-C)-InVivo在文献中得到引用

A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma Mutations [ Cancer Research, March 26, 2026, 86(12):3074-3091] PubMed: 41886621
A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma Mutations [ Cancer Research, June 15, 2026, Volume 86, Issue 12] PubMed: 41886621
A Deep Learning–Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma Mutations [ Cancer Research, 2026, 3074-3091] PubMed: 41886621

禁止用于人体及治疗！